Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds

619 indexed citations

Abstract

loading...

About

This paper, published in 2011, received 619 indexed citations. Written by Fatiah Issa, Michael Kassiou and Louis M. Rendina covering the research area of Materials Chemistry and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Radiology, Nuclear Medicine and Imaging (566 citations), Organic Chemistry (256 citations) and Materials Chemistry (174 citations). Published in Chemical Reviews.

Countries where authors are citing Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds

Specialization
Citations

This map shows the geographic impact of Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds more than expected).

Fields of papers citing Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Boron in Drug Discovery: Carboranes as Unique Pharmacophores in Biologically Active Compounds.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1021/cr2000866.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026